A class of antipsychotic medications has a newly updated safety label that includes a warning for pregnant women and women of childbearing age to avoid use of the drugs because of a risk of extrapyramidal symptoms (EPS) and withdrawal symptoms in newborn babies, according to the Food and Drug Administration (FDA) monthly safety labeling updates report. Extrapyramidal symptoms include a variety of movement disorders such as those that cause the inability to initiate movement and the inability to remain motionless. The new warning labels stress that the products should be used during pregnancy only if the potential benefit justifies the ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.